Cytokine release syndrome as a consequence of check point inhibitors nivolimumab and iplimumab

---

Letter to editor

Author Details : Amrita Shah, Pradeep Rangappa, Ipe Jacob*, Karthik Rao, Neelesh Reddy

Volume : 9, Issue : 4, Year : 2022

Article Page : 392-394

https://doi.org/10.18231/j.ijpo.2022.096

Suggest article by email

Get Permission

---

Abstract

 

How to cite : Shah A, Rangappa P, Jacob I, Rao K, Reddy N, Cytokine release syndrome as a consequence of check point inhibitors nivolimumab and iplimumab. Indian J Pathol Oncol 2022;9(4):392-394

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.